Cambridge, United Kingdom

Hollie Mccarron

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Hollie McCarron

Introduction

Hollie McCarron is a notable inventor based in Cambridge, GB. She has made significant strides in the field of cancer treatment through her innovative research and development of heterocyclic compounds. Her work is not only groundbreaking but also essential in the ongoing fight against cancer.

Latest Patents

Hollie McCarron holds 1 patent for her invention titled "Heterocyclic compounds for use in the treatment of cancer." This patent relates to heterocyclic amide derivatives and their application in the treatment and prophylaxis of cancer. It also encompasses compositions containing these derivatives and the processes for their preparation.

Career Highlights

Hollie is currently employed at Artios Pharma Limited, where she continues to contribute to the advancement of cancer therapies. Her role at the company allows her to collaborate with other experts in the field, enhancing the impact of her work.

Collaborations

Hollie has worked alongside notable colleagues such as Peter Blencowe and Mark Charles. Their combined expertise fosters a collaborative environment that drives innovation in cancer treatment.

Conclusion

Hollie McCarron's contributions to cancer research through her patented inventions highlight her dedication to improving patient outcomes. Her work at Artios Pharma Limited exemplifies the importance of innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…